Jennifer Cozart, MD

Jennifer R. Cozart, M.D. is a highly skilled surgeon with extensive experience in cardiovascular, thoracic and general surgery procedures. Her practice encompasses all aspects of these fields, with a special focus on minimally invasive cardiothoracic and endovascular techniques. She is also committed to raising the awareness of and treating cardiovascular disease in women.

Show full bio

Dr. Cozart holds medical staff appointments at Baylor St. Luke’s Medical Center and The Texas Heart Institute in Houston. She received her Doctor of Medicine degree from The University of Texas Medical Branch at Galveston, Texas in 2003 after receiving a Bachelor of Arts degree in 1998 from The University of Texas at Austin. Upon completion of a General Surgery Residency at The University of Texas Medical Branch in 2008, she completed a Cardiothoracic and Vascular Surgery Residency at The Texas Heart Institute and Baylor College of Medicine.

She is board certified by the American Board of Surgery and licensed to practice medicine by the State of Texas. Dr. Cozart is a Fellow of the American College of Surgeons and a Fellow of the American College of Cardiology. She is also an active member of numerous medical and scientific societies including the American Medical Association, Texas Medical Association, Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), the Denton A. Cooley Cardiovascular Surgical Society, Society of Thoracic Surgery, and Women in Thoracic Surgery.

Texas Heart Institute Positions

Interests

  • Hybrid Atrial Fibrillation Program

Education

  • Medical School:

    The University of Texas Medical Branch, Galveston, Texas, 2003 

  • Residency:

    The University of Texas Medical Branch

  • Fellowships:

    Texas Heart Institute and Baylor College of Medicine

Academic & Clinical Affiliations

Honors, Awards and Memberships

Publications

4862227 UWPBQ9HY 1 alternatives-to-animal-experimentation 10 date desc Del Prete 1877 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22F8VDBG2V%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stone%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BStone%2C%20G.%20W.%2C%20Kappetein%2C%20A.%20P.%2C%20Sabik%2C%20J.%20F.%20et%20al.%20%282019%29.%20Five-Year%20Outcomes%20after%20PCI%20or%20CABG%20for%20Left%20Main%20Coronary%20Disease.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B381%26lt%3B%5C%2Fi%26gt%3B%2C%201820%26%23x2013%3B1830.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1909406%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1909406%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Five-Year%20Outcomes%20after%20PCI%20or%20CABG%20for%20Left%20Main%20Coronary%20Disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregg%20W.%22%2C%22lastName%22%3A%22Stone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20Pieter%22%2C%22lastName%22%3A%22Kappetein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20F.%22%2C%22lastName%22%3A%22Sabik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20J.%22%2C%22lastName%22%3A%22Pocock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Claude%22%2C%22lastName%22%3A%22Morice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Puskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Kandzari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimitri%22%2C%22lastName%22%3A%22Karmpaliotis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Morris%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Lembo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Banning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9la%22%2C%22lastName%22%3A%22Merkely%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ferenc%22%2C%22lastName%22%3A%22Horkay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piet%20W.%22%2C%22lastName%22%3A%22Boonstra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ad%20J.%22%2C%22lastName%22%3A%22van%20Boven%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Imre%22%2C%22lastName%22%3A%22Ungi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabor%22%2C%22lastName%22%3A%22Bog%5Cu00e1ts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samer%22%2C%22lastName%22%3A%22Mansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Noiseux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manel%22%2C%22lastName%22%3A%22Sabat%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Pomar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Hickey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Gershlick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pawel%20E.%22%2C%22lastName%22%3A%22Buszman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrzej%22%2C%22lastName%22%3A%22Bochenek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erick%22%2C%22lastName%22%3A%22Schampaert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Modolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Gregson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20A.%22%2C%22lastName%22%3A%22Simonton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Mehran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioanna%22%2C%22lastName%22%3A%22Kosmidou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22G%5Cu00e9n%5Cu00e9reux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%22%2C%22lastName%22%3A%22Crowley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ovidiu%22%2C%22lastName%22%3A%22Dressler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20W.%22%2C%22lastName%22%3A%22Serruys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22EXCEL%20Trial%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Long-term%20outcomes%20after%20percutaneous%20coronary%20intervention%20%28PCI%29%20with%20contemporary%20drug-eluting%20stents%2C%20as%20compared%20with%20coronary-artery%20bypass%20grafting%20%28CABG%29%2C%20in%20patients%20with%20left%20main%20coronary%20artery%20disease%20are%20not%20clearly%20established.%5CnMETHODS%3A%20We%20randomly%20assigned%201905%20patients%20with%20left%20main%20coronary%20artery%20disease%20of%20low%20or%20intermediate%20anatomical%20complexity%20%28according%20to%20assessment%20at%20the%20participating%20centers%29%20to%20undergo%20either%20PCI%20with%20fluoropolymer-based%20cobalt-chromium%20everolimus-eluting%20stents%20%28PCI%20group%2C%20948%20patients%29%20or%20CABG%20%28CABG%20group%2C%20957%20patients%29.%20The%20primary%20outcome%20was%20a%20composite%20of%20death%2C%20stroke%2C%20or%20myocardial%20infarction.%5CnRESULTS%3A%20At%205%20years%2C%20a%20primary%20outcome%20event%20had%20occurred%20in%2022.0%25%20of%20the%20patients%20in%20the%20PCI%20group%20and%20in%2019.2%25%20of%20the%20patients%20in%20the%20CABG%20group%20%28difference%2C%202.8%20percentage%20points%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%20-0.9%20to%206.5%3B%20P%5Cu2009%3D%5Cu20090.13%29.%20Death%20from%20any%20cause%20occurred%20more%20frequently%20in%20the%20PCI%20group%20than%20in%20the%20CABG%20group%20%28in%2013.0%25%20vs.%209.9%25%3B%20difference%2C%203.1%20percentage%20points%3B%2095%25%20CI%2C%200.2%20to%206.1%29.%20In%20the%20PCI%20and%20CABG%20groups%2C%20the%20incidences%20of%20definite%20cardiovascular%20death%20%285.0%25%20and%204.5%25%2C%20respectively%3B%20difference%2C%200.5%20percentage%20points%3B%2095%25%20CI%2C%20-1.4%20to%202.5%29%20and%20myocardial%20infarction%20%2810.6%25%20and%209.1%25%3B%20difference%2C%201.4%20percentage%20points%3B%2095%25%20CI%2C%20-1.3%20to%204.2%29%20were%20not%20significantly%20different.%20All%20cerebrovascular%20events%20were%20less%20frequent%20after%20PCI%20than%20after%20CABG%20%283.3%25%20vs.%205.2%25%3B%20difference%2C%20-1.9%20percentage%20points%3B%2095%25%20CI%2C%20-3.8%20to%200%29%2C%20although%20the%20incidence%20of%20stroke%20was%20not%20significantly%20different%20between%20the%20two%20groups%20%282.9%25%20and%203.7%25%3B%20difference%2C%20-0.8%20percentage%20points%3B%2095%25%20CI%2C%20-2.4%20to%200.9%29.%20Ischemia-driven%20revascularization%20was%20more%20frequent%20after%20PCI%20than%20after%20CABG%20%2816.9%25%20vs.%2010.0%25%3B%20difference%2C%206.9%20percentage%20points%3B%2095%25%20CI%2C%203.7%20to%2010.0%29.%5CnCONCLUSIONS%3A%20In%20patients%20with%20left%20main%20coronary%20artery%20disease%20of%20low%20or%20intermediate%20anatomical%20complexity%2C%20there%20was%20no%20significant%20difference%20between%20PCI%20and%20CABG%20with%20respect%20to%20the%20rate%20of%20the%20composite%20outcome%20of%20death%2C%20stroke%2C%20or%20myocardial%20infarction%20at%205%20years.%20%28Funded%20by%20Abbott%20Vascular%3B%20EXCEL%20ClinicalTrials.gov%20number%2C%20NCT01205776.%29.%22%2C%22date%22%3A%222019-11-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa1909406%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UWPBQ9HY%22%5D%2C%22dateModified%22%3A%222022-05-12T20%3A39%3A09Z%22%7D%7D%2C%7B%22key%22%3A%229H9ZHMZB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stone%20et%20al.%22%2C%22parsedDate%22%3A%222016-12-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BStone%2C%20G.%20W.%2C%20Sabik%2C%20J.%20F.%2C%20Serruys%2C%20P.%20W.%20et%20al.%20%282016%29.%20Everolimus-Eluting%20Stents%20or%20Bypass%20Surgery%20for%20Left%20Main%20Coronary%20Artery%20Disease.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B375%26lt%3B%5C%2Fi%26gt%3B%2C%202223%26%23x2013%3B2235.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1610227%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1610227%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Everolimus-Eluting%20Stents%20or%20Bypass%20Surgery%20for%20Left%20Main%20Coronary%20Artery%20Disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregg%20W.%22%2C%22lastName%22%3A%22Stone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20F.%22%2C%22lastName%22%3A%22Sabik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20W.%22%2C%22lastName%22%3A%22Serruys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20A.%22%2C%22lastName%22%3A%22Simonton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22G%5Cu00e9n%5Cu00e9reux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Puskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Kandzari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Claude%22%2C%22lastName%22%3A%22Morice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Lembo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Morris%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20P.%22%2C%22lastName%22%3A%22Taggart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Banning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9la%22%2C%22lastName%22%3A%22Merkely%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ferenc%22%2C%22lastName%22%3A%22Horkay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piet%20W.%22%2C%22lastName%22%3A%22Boonstra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ad%20J.%22%2C%22lastName%22%3A%22van%20Boven%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Imre%22%2C%22lastName%22%3A%22Ungi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabor%22%2C%22lastName%22%3A%22Bog%5Cu00e1ts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samer%22%2C%22lastName%22%3A%22Mansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Noiseux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manel%22%2C%22lastName%22%3A%22Sabat%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Pomar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Hickey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Gershlick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pawel%22%2C%22lastName%22%3A%22Buszman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrzej%22%2C%22lastName%22%3A%22Bochenek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erick%22%2C%22lastName%22%3A%22Schampaert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ovidiu%22%2C%22lastName%22%3A%22Dressler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioanna%22%2C%22lastName%22%3A%22Kosmidou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Mehran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20J.%22%2C%22lastName%22%3A%22Pocock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20Pieter%22%2C%22lastName%22%3A%22Kappetein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22EXCEL%20Trial%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Patients%20with%20obstructive%20left%20main%20coronary%20artery%20disease%20are%20usually%20treated%20with%20coronary-artery%20bypass%20grafting%20%28CABG%29.%20Randomized%20trials%20have%20suggested%20that%20drug-eluting%20stents%20may%20be%20an%20acceptable%20alternative%20to%20CABG%20in%20selected%20patients%20with%20left%20main%20coronary%20disease.%5CnMETHODS%3A%20We%20randomly%20assigned%201905%20eligible%20patients%20with%20left%20main%20coronary%20artery%20disease%20of%20low%20or%20intermediate%20anatomical%20complexity%20to%20undergo%20either%20percutaneous%20coronary%20intervention%20%28PCI%29%20with%20fluoropolymer-based%20cobalt-chromium%20everolimus-eluting%20stents%20%28PCI%20group%2C%20948%20patients%29%20or%20CABG%20%28CABG%20group%2C%20957%20patients%29.%20Anatomic%20complexity%20was%20assessed%20at%20the%20sites%20and%20defined%20by%20a%20Synergy%20between%20Percutaneous%20Coronary%20Intervention%20with%20Taxus%20and%20Cardiac%20Surgery%20%28SYNTAX%29%20score%20of%2032%20or%20lower%20%28the%20SYNTAX%20score%20reflects%20a%20comprehensive%20angiographic%20assessment%20of%20the%20coronary%20vasculature%2C%20with%200%20as%20the%20lowest%20score%20and%20higher%20scores%20%5Bno%20upper%20limit%5D%20indicating%20more%20complex%20coronary%20anatomy%29.%20The%20primary%20end%20point%20was%20the%20rate%20of%20a%20composite%20of%20death%20from%20any%20cause%2C%20stroke%2C%20or%20myocardial%20infarction%20at%203%20years%2C%20and%20the%20trial%20was%20powered%20for%20noninferiority%20testing%20of%20the%20primary%20end%20point%20%28noninferiority%20margin%2C%204.2%20percentage%20points%29.%20Major%20secondary%20end%20points%20included%20the%20rate%20of%20a%20composite%20of%20death%20from%20any%20cause%2C%20stroke%2C%20or%20myocardial%20infarction%20at%2030%20days%20and%20the%20rate%20of%20a%20composite%20of%20death%2C%20stroke%2C%20myocardial%20infarction%2C%20or%20ischemia-driven%20revascularization%20at%203%20years.%20Event%20rates%20were%20based%20on%20Kaplan-Meier%20estimates%20in%20time-to-first-event%20analyses.%5CnRESULTS%3A%20At%203%20years%2C%20a%20primary%20end-point%20event%20had%20occurred%20in%2015.4%25%20of%20the%20patients%20in%20the%20PCI%20group%20and%20in%2014.7%25%20of%20the%20patients%20in%20the%20CABG%20group%20%28difference%2C%200.7%20percentage%20points%3B%20upper%2097.5%25%20confidence%20limit%2C%204.0%20percentage%20points%3B%20P%3D0.02%20for%20noninferiority%3B%20hazard%20ratio%2C%201.00%3B%2095%25%20confidence%20interval%2C%200.79%20to%201.26%3B%20P%3D0.98%20for%20superiority%29.%20The%20secondary%20end-point%20event%20of%20death%2C%20stroke%2C%20or%20myocardial%20infarction%20at%2030%20days%20occurred%20in%204.9%25%20of%20the%20patients%20in%20the%20PCI%20group%20and%20in%207.9%25%20in%20the%20CABG%20group%20%28P%26lt%3B0.001%20for%20noninferiority%2C%20P%3D0.008%20for%20superiority%29.%20The%20secondary%20end-point%20event%20of%20death%2C%20stroke%2C%20myocardial%20infarction%2C%20or%20ischemia-driven%20revascularization%20at%203%20years%20occurred%20in%2023.1%25%20of%20the%20patients%20in%20the%20PCI%20group%20and%20in%2019.1%25%20in%20the%20CABG%20group%20%28P%3D0.01%20for%20noninferiority%2C%20P%3D0.10%20for%20superiority%29.%5CnCONCLUSIONS%3A%20In%20patients%20with%20left%20main%20coronary%20artery%20disease%20and%20low%20or%20intermediate%20SYNTAX%20scores%20by%20site%20assessment%2C%20PCI%20with%20everolimus-eluting%20stents%20was%20noninferior%20to%20CABG%20with%20respect%20to%20the%20rate%20of%20the%20composite%20end%20point%20of%20death%2C%20stroke%2C%20or%20myocardial%20infarction%20at%203%20years.%20%28Funded%20by%20Abbott%20Vascular%3B%20EXCEL%20ClinicalTrials.gov%20number%2C%20NCT01205776%20.%29.%22%2C%22date%22%3A%22Dec%2008%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa1610227%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%228HHBIBI6%22%2C%22UWPBQ9HY%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222022-05-12T20%3A43%3A47Z%22%7D%7D%2C%7B%22key%22%3A%227GFTD44H%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schwill%20et%20al.%22%2C%22parsedDate%22%3A%222010%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSchwill%2C%20S.%2C%20%26lt%3Bstrong%26gt%3BDel%20Prete%26lt%3B%5C%2Fstrong%26gt%3B%2C%20J.%2C%20Cooley%2C%20D.%20A.%20et%20al.%20%282010%29.%20Two%20scimitar%20veins%20in%20an%20adult%3A%20repair%20through%20a%20right%20thoracotomy%20without%20cardiopulmonary%20bypass.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B37%26lt%3B%5C%2Fi%26gt%3B%2C%20358%26%23x2013%3B360%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Two%20scimitar%20veins%20in%20an%20adult%3A%20repair%20through%20a%20right%20thoracotomy%20without%20cardiopulmonary%20bypass%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Schwill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Del%20Prete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denton%20A.%22%2C%22lastName%22%3A%22Cooley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20L.%20S.%22%2C%22lastName%22%3A%22Morales%22%7D%5D%2C%22abstractNote%22%3A%22Scimitar%20syndrome%20is%20a%20rare%20but%20serious%20congenital%20condition%20that%20consists%20of%20anomalous%20pulmonary%20venous%20drainage%20of%20the%20right%20lung%20to%20the%20inferior%20vena%20cava.%20The%20appearance%20on%20chest%20radiography%20resembles%20a%20curved%20Turkish%20sword%2C%20or%20scimitar.%20Scimitar%20syndrome%20is%20associated%20with%20other%20anomalies%2C%20including%20hypoplasia%20of%20the%20right%20lung%2C%20dextroposition%20of%20the%20heart%2C%20anomalous%20systemic%20arterial%20supply%20to%20the%20right%20lung%2C%20and%20atrial%20septal%20defect.%20Clinical%20manifestations%20in%20infants%20include%20severe%20tachypnea%20and%20cyanosis.%20Adult%20patients%20may%20present%20with%20dyspnea%20and%20increased%20fatigue.%20Few%20adult%20cases%20have%20been%20reported%20in%20the%20medical%20literature.%20Classical%20surgical%20repair%20involves%20diversion%20of%20the%20scimitar%20venous%20flow%20into%20the%20left%20atrium%20with%20a%20baffle%2C%20requiring%20the%20use%20of%20cardiopulmonary%20bypass%20and%20deep%20hypothermic%20circulatory%20arrest.%20Herein%2C%20we%20report%20the%20case%20of%20a%2042-year-old%20woman%20with%202%20scimitar%20veins%20who%20underwent%20corrective%20surgery%20at%20our%20center%20without%20the%20use%20of%20cardiopulmonary%20bypass.%20We%20also%20comment%20on%20the%20importance%20of%20a%20patient%26%23039%3Bs%20lung%20hypoplasia%20in%20the%20decision%20to%20repair%20the%20defect%20through%20a%20right%20thoracotomy.%22%2C%22date%22%3A%222010%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UWPBQ9HY%22%5D%2C%22dateModified%22%3A%222022-05-12T20%3A39%3A09Z%22%7D%7D%5D%7D
Stone, G. W., Kappetein, A. P., Sabik, J. F. et al. (2019). Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med 381, 1820–1830. https://doi.org/10.1056/NEJMoa1909406.
Stone, G. W., Sabik, J. F., Serruys, P. W. et al. (2016). Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med 375, 2223–2235. https://doi.org/10.1056/NEJMoa1610227.
Schwill, S., Del Prete, J., Cooley, D. A. et al. (2010). Two scimitar veins in an adult: repair through a right thoracotomy without cardiopulmonary bypass. Tex Heart Inst J 37, 358–360

Recent News

See All

Celebrating Women in Science at The Texas Heart Institute

As the world celebrates the International Day of Women and Girls in Science, a day dedicated to recognizing the invaluable...

Read more

Dr. Jennifer Cozart Pioneers First Use of AtriClip FLEX-Mini in Texas, Advancing Heart Surgery Innovation

Another groundbreaking moment in cardiovascular surgery has again unfolded at The Texas Heart Institute. Dr. Jennifer Cozart, a leading cardiovascular...

Read more

Texas Heart Institute Surgeons Recognized for Quality Care

HOUSTON, TX, February 15, 2024— Three Texas Heart Institute Center for Cardiovascular Care surgeons, Drs. James Livesay, Jennifer Cozart and...

Read more